Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 19;21(12):4381.
doi: 10.3390/ijms21124381.

Preimplantation Genetic Testing: Where We Are Today

Affiliations
Review

Preimplantation Genetic Testing: Where We Are Today

Ermanno Greco et al. Int J Mol Sci. .

Abstract

Background: Preimplantation genetic testing (PGT) is widely used today in in-vitro fertilization (IVF) centers over the world for selecting euploid embryos for transfer and to improve clinical outcomes in terms of embryo implantation, clinical pregnancy, and live birth rates.

Methods: We report the current knowledge concerning these procedures and the results from different clinical indications in which PGT is commonly applied.

Results: This paper illustrates different molecular techniques used for this purpose and the clinical significance of the different oocyte and embryo stage (polar bodies, cleavage embryo, and blastocyst) at which it is possible to perform sampling biopsies for PGT. Finally, genetic origin and clinical significance of embryo mosaicism are illustrated.

Conclusions: The preimplantation genetic testing is a valid technique to evaluated embryo euploidy and mosaicism before transfer.

Keywords: biopsy; endometrium; euploid embryo; implantation; in-vitro fertilization; mosaicism; pregnancy; preimplantation genetic screening.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
In the figure, the sequence of a blastocyst biopsy laser assisted is shown. The blastocyst is initially orientated by mean of the holding pipette in order to keep the inner cell mass as far as possible from the site of biopsy (A). Subsequently, the biopsy pipette is introduced through a hole performed with laser in the zona pellucida and a little number of trophectoderm cells are gently aspirated (B,C). Finally, the removed trophectoderm cells is transferred in a tube for the genetic analysis (D). The white narrow indicates the inner cell mass. The black narrow indicates the removed trophectoderm cells.

References

    1. Kupka M.S., Ferraretti A.P., de Mouzon J., Erb K., D’Hooghe T., Castilla J.A., Calhaz-Jorge C., De Geyter C. Assisted reproductive technology in Europe, 2010: Results generated from European registers by ESHRE. Hum. Reprod. 2014;29:2099–2113. doi: 10.1093/humrep/deu175. - DOI - PubMed
    1. Paternot G., Devroe J., Debrock S., D’Hooghe T.M., Spiessens C. Intra- and inter-observer analysis in the morphological assessment of early-stage embryos. Reprod. Biol. Endocrinol. 2009;7:105. doi: 10.1186/1477-7827-7-105. - DOI - PMC - PubMed
    1. Abeyta M., Behr B. Morphological assessment of embryo viability. Semin. Reprod. Med. 2014;32:114–126. doi: 10.1055/s-0033-1363553. - DOI - PubMed
    1. Minasi M.G., Colasante A., Riccio T., Ruberti A., Casciani V., Scarselli F., Spinella F., Fiorentino F., Varricchio M.T., Greco E. Correlation between aneuploidy, standard morphology evaluation and morphokinetic development in 1730 biopsied blastocysts: A consecutive case series study. Hum. Reprod. 2016;31:2245–2254. doi: 10.1093/humrep/dew183. - DOI - PubMed
    1. Desai N., Ploskonk S., Goodman L.R., Austin C., Goldberg J., Falcone T. Analysis of embryo morphokinetics, multinucleation and cleavage anomalies using continuous time-lapse monitoring in blastocyst transfer cycles. Reprod. Biol. Endocrinol. 2014;20:12–54. doi: 10.1186/1477-7827-12-54. - DOI - PMC - PubMed